Skip to main content

Table 2 Clinical and radiological characteristics of the study cohort

From: The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy

Characteristics Parameter N (%)
Age (years) <60/ ≥60 212 (59.2)/146 (40.8)
Gender Female / Male 142 (39.7) /216 (60.3)
WBC(× 109/L) <10/≥10 329 (91.9) /29 (8.1)
Neutrophil count(×109/L) <7/≥7 289 (80.7) /69 (19.3)
Lymphoeyte count(×109/L) <4/≥4 348 (97.2)/10 (2.8)
HGB(g/L) <100/≥100 170 (47.5) /188 (52.5)
PLT(×109/L) <300/≥300 191 (53.4) /167 (46.6)
ALT(U/L) <40/≥40 91 (25.4)/267 (74.6)
AST(U/L) <45/≥45 96 (26.8) /262 (73.2)
ALB(g/L) <35/≥35 70 (19.6) /288 (80.4)
TBIL (mmol/L) <20.5/≥20.5 80 (22.3) /278 (77.7)
IBIL (mmol/L) <15/≥15 182 (50.8) /176 (49.2)
CRP (mg/L) <8/≥8 108 (30.2) /250 (69.8)
mGPS 0 / 1 / 2 222 (62.0) /87 (24.3) /49 (13.7)
CA19–9(U/ml) <35/≥35 90 (25.1) /268 (74.9)
CEA (μg/L) <5/≥5 261 (72.9) / 97 (27.1)
TNM IA/IB/IIA/IIB/III 72 (20.1) / 93 (26.0) / 34 (9.5) /
104 (29.1) / 55 (15.4)
LN metastasis absent/present 199 (55.6) /159 (44.4)
Tumor differentiation high/ moderate / poor 7 (2.0) / 188 (52.5) / 163 (45.5)
NLR ≤3.32 />3.32 226 (63.1) /132 (36.9)
PLR ≤99.02/>99.02 31 (8.7) / 327 (91.3)
dNLR ≤1.94/>1.94 204 (57.0)/154 (43.0)
mGPS 0/1/2 222 (62.0) /87 (24.3) /49 (13.7)
PNI 0 / 1 277 (77.4) /81 (22.6)
PI 0 / 1 / 2 216 (60.3) / 119 (33.2) / 23 (6.4)
Chemotherapy No / Yes 192 (53.6) / 166 (46.4)
  1. HGB Hemoglobin, PLT Platelets, ALT Alanine aminotransferase, AST Aspartate aminotransferase, TBIL Total serum bilirubin, IBIL Indirect serum bilirubin, AFP Alpha-fetoprotein, CA19–9 Carbohydrate antigen 19–9, TNM Tumour-node-metastasis, CEA Carcinoembryonic antigen, LN Lymph node. Other Abbreviations as in Table 1